Xeris Pharmaceuticals Inc reported $131.26M in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acelrx Pharmaceuticals ACRX:US $ 72.26M 7.32M
Acura Pharmaceuticals ACUR:US 1.9M 22K
Eli Lilly And LLY:US $ 48187M 378M
Endo International Ordinary Shares ENDP:US $ 9246.55M 40.3M
Horizon Pharma HZNP:US $ 8608.69M 401.27M
JAZZ PHA JAZZ:US $ 12478.15M 734.84M
Nektar Therapeutics NKTR:US $ 1277.24M 94.11M
Pacira Pharmaceuticals PCRX:US $ 1356M 30.17M
Perrigo Ordinary Shares PRGO:US $ 10915.9M 314.4M
Supernus Pharmaceuticals SUPN:US $ 1555.04M 18.02M
Teva Pharmaceutical Industries TEVA:US $ 47851M 1344M
Zogenix ZGNX:US $ 496.99M 43.09M